Literature DB >> 9397243

Insulin resistance is related to silent cerebral infarction in patients with essential hypertension.

K Kamide1, H Rakugi, N Nakano, M Ohishi, Y Nakata, S Takami, T Katsuya, J Higaki, T Ogihara.   

Abstract

Recently, hyperinsulinemia or insulin resistance has been suggested to be a risk factor for cardiovascular diseases. We evaluated the role of insulin resistance in the occurrence of silent cerebral infarction in 28 patients with essential hypertension (40 to 75 years, 157 +/- 4/89 +/- 2 mm Hg). Patients with diabetes mellitus or obesity (BMI > or = 30) were excluded. Insulin resistance was evaluated by means of constant glucose infusion rate (M value) during euglycemic-hyperinsulinemic glucose clamp test. Infarction was defined as a focal area with prolonged T1 and T2 relaxation times that was > 5 mm in diameter on brain magnetic resonance imaging. The severity of periventricular hyperlucency was evaluated by the distribution of the high intensity area. The number of silent infarctions significantly correlated only with the M value (F = 7.58, R2 = 0.23, P = .01) in multiple regression analysis using all variables: age, blood pressure, smoking history, lipid profile, levels of plasma glucose and insulin on fasting, and total amounts during 75-g OGTT. However, the severity of periventricular hyperlucency did not show a correlation with any factors. The occurrence of cerebral infarction was significantly correlated with thickening of the intima-media complex (IMC) of the common carotid artery on B-mode ultrasonography (F = 8.43, R2 = 0.25, P < .01). In conclusion, insulin resistance and thickening of IMC show a close relationship with the occurrence of silent cerebral infarction. Therefore, it may be important to improve insulin resistance for prevention of cerebral infarction in essential hypertensives.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9397243     DOI: 10.1016/s0895-7061(97)00282-3

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  4 in total

Review 1.  Earlier management of subjects who are prone to hypertension and diabetes mellitus.

Authors:  Hiromi Rakugi; Toshio Ogihara
Journal:  Curr Diab Rep       Date:  2004-04       Impact factor: 4.810

Review 2.  Vascular signaling pathways in the metabolic syndrome.

Authors:  Hiromi Rakugi; Kei Kamide; Toshio Ogihara
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

3.  Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study.

Authors:  Rohit R Das; Sudha Seshadri; Alexa S Beiser; Margaret Kelly-Hayes; Rhoda Au; Jayandra J Himali; Carlos S Kase; Emelia J Benjamin; Joseph F Polak; Christopher J O'Donnell; Mitsuhiro Yoshita; Ralph B D'Agostino; Charles DeCarli; Philip A Wolf
Journal:  Stroke       Date:  2008-06-26       Impact factor: 7.914

4.  Insulin Resistance in Skeletal Muscle of Chronic Stroke.

Authors:  Alice S Ryan; Charlene Hafer-Macko; Heidi K Ortmeyer
Journal:  Brain Sci       Date:  2020-12-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.